guest ::
| Home > Publications database > Synthesis and evaluation of tetrahydrobenzo[cd]indole derivatives as glycogen phosphorylase inhibitors > print |
| Home > Publications database > Synthesis and evaluation of tetrahydrobenzo[cd]indole derivatives as glycogen phosphorylase inhibitors > print |
| 001 | 626501 | ||
| 005 | 20250723105854.0 | ||
| 024 | 7 | _ | |a 10.1007/s00044-025-03384-7 |2 doi |
| 024 | 7 | _ | |a 1054-2523 |2 ISSN |
| 024 | 7 | _ | |a 1554-8120 |2 ISSN |
| 024 | 7 | _ | |a WOS:001415791900001 |2 WOS |
| 024 | 7 | _ | |a openalex:W4407270496 |2 openalex |
| 037 | _ | _ | |a PUBDB-2025-01454 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Arunrattiyakorn, Panarat |0 P:(DE-HGF)0 |b 0 |e Corresponding author |
| 245 | _ | _ | |a Synthesis and evaluation of tetrahydrobenzo[cd]indole derivatives as glycogen phosphorylase inhibitors |
| 260 | _ | _ | |a Cambridge, Mass. [u.a.] |c 2025 |b Birkhäuser Boston |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1745829313_477593 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a Waiting for fulltext |
| 520 | _ | _ | |a A series of tetrahydrobenzo[cd]indole derivatives was synthesized by condensation of a fungal metabolite hyphodermin A, a naphtho[1,2-c]furan-3,9-dione derivative, and various anilines in methanol. Using this approach, ten analogs (3a–3j) were synthesized and tested as inhibitors against glycogen phosphorylase (GP). While compounds 3e and 3i bearing hydrophobic bromo and trifluoromethyl groups showed moderated inhibition (Ki = 32.3–57.4 μΜ), compound 3g with hydroxy group had the most potent activity with a Ki value of 7.9 ± 0.7 μΜ against human liver GPa. An X-ray crystallography study of the rabbit muscle GPb-3g complexes revealed that this inhibitor binds at a subsite within the indole binding site of GP which has not been previously observed to bind ligands. |
| 536 | _ | _ | |a 6G3 - PETRA III (DESY) (POF4-6G3) |0 G:(DE-HGF)POF4-6G3 |c POF4-6G3 |f POF IV |x 0 |
| 536 | _ | _ | |a iNEXT-Discovery - Infrastructure for transnational access and discovery in structural biology (871037) |0 G:(EU-Grant)871037 |c 871037 |f H2020-INFRAIA-2019-1 |x 1 |
| 588 | _ | _ | |a Dataset connected to CrossRef, Journals: bib-pubdb1.desy.de |
| 693 | _ | _ | |a PETRA III |f PETRA Beamline P13 |1 EXP:(DE-H253)PETRAIII-20150101 |0 EXP:(DE-H253)P-P13-20150101 |6 EXP:(DE-H253)P-P13-20150101 |x 0 |
| 700 | 1 | _ | |a Juiprasert, Chanitha |b 1 |
| 700 | 1 | _ | |a Koulas, Symeon M. |b 2 |
| 700 | 1 | _ | |a Boonsri, Pornthip |b 3 |
| 700 | 1 | _ | |a Aree, Thammarat |b 4 |
| 700 | 1 | _ | |a Yagi-Utsumi, Maho |b 5 |
| 700 | 1 | _ | |a Kato, Koichi |b 6 |
| 700 | 1 | _ | |a Leonidas, Demetres D. |b 7 |
| 773 | _ | _ | |a 10.1007/s00044-025-03384-7 |g Vol. 34, no. 4, p. 870 - 881 |0 PERI:(DE-600)2191978-1 |n 4 |p 870 - 881 |t Medicinal chemistry research |v 34 |y 2025 |x 1054-2523 |
| 856 | 4 | _ | |u https://link.springer.com/article/10.1007/s00044-025-03384-7#article-info |
| 856 | 4 | _ | |u https://bib-pubdb1.desy.de/record/626501/files/Synthesis%20and%20evaluation%20of%20tetrahydrobenzo%5Bcd%5Dindole%20derivatives%20as%20glycogen%20phosphorylase%20inhibitors.pdf |y Restricted |
| 909 | C | O | |o oai:bib-pubdb1.desy.de:626501 |p openaire |p VDB |p ec_fundedresources |
| 913 | 1 | _ | |a DE-HGF |b Forschungsbereich Materie |l Großgeräte: Materie |1 G:(DE-HGF)POF4-6G0 |0 G:(DE-HGF)POF4-6G3 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-600 |4 G:(DE-HGF)POF |v PETRA III (DESY) |x 0 |
| 914 | 1 | _ | |y 2025 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2024-12-13 |w ger |
| 915 | _ | _ | |a DEAL Springer |0 StatID:(DE-HGF)3002 |2 StatID |d 2024-12-13 |w ger |
| 915 | _ | _ | |a DEAL Springer |0 StatID:(DE-HGF)3002 |2 StatID |d 2024-12-13 |w ger |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b MED CHEM RES : 2022 |d 2024-12-13 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2024-12-13 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2024-12-13 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2024-12-13 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2024-12-13 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2024-12-13 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2024-12-13 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2024-12-13 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2024-12-13 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2024-12-13 |
| 915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |d 2024-12-13 |
| 920 | 1 | _ | |0 I:(DE-H253)EMBL-User-20120814 |k EMBL-User |l EMBL-User |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-H253)EMBL-User-20120814 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|